Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Adrenocortical Carcinoma Market Report 2026: Innovative Therapies Set to Transform the $4 Billion Adrenocortical Carcinoma Landscape

globenewswire.com
MRK Merck is listed as a key player in the adrenocortical carcinoma market. The article does not provide specific details on its performance or contributions, thus the sentiment is neutral. AZN AstraZeneca is named as a key company in the adrenocortical carcinoma market. The article mentions its presence but does not offer specific details on its activities or market impact, resulting in a neutral sentiment. LLY Eli Lilly is identified as a key player in the adrenocortical carcinoma market. The article lists the company without providing specific performance data or strategic insights, leading to a neutral sentiment. SNY Sanofi is mentioned as a key company within the adrenocortical carcinoma market. The article does not elaborate on its specific contributions or market standing, hence the sentiment is neutral.

Adrenocortical Carcinoma Market Report 2026: Innovative Therapies Set to Transform the $4 Billion Adrenocortical Carcinoma Landscape Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Adrenocortical Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The adrenocortical carcinoma market is on a growth trajectory, with projections showing an increase from $3.76 billion in 2025 to $3.92 billion in 2026, at a CAGR of 4.4%. This growth stems from heightened diagnosis through imaging technologies, an expansion of specialized cancer research centers, and increased patient awareness.

Looking toward 2030, the market is expected to reach $4.62 billion, with a CAGR of 4.2%, supported by advancements in targeted therapies and minimally invasive procedures, as well as the adoption of combination therapy protocols.

The rise in the prevalence of rare cancers is a significant driver of this market's expansion. Advances in diagnostic technologies have improved early detection, especially in rare cancer types like adrenocortical carcinoma (ACC), which are aggressive and have specific diagnostic and therapeutic needs. A report by the International Agency for Research on Cancer highlights that rare cancers comprise about 25% of all cancer diagnoses globally.

Key market players are focusing on innovative therapies, including small-molecule drugs that target specific tumor pathways. Orphagen Pharmaceuticals recently announced FDA's Rare Pediatric Disease Designation for its investigational drug OR-449, targeting pediatric ACC. This underscores ongoing innovation in the treatment landscape.

In business developments, Esteve Pharmaceuticals acquired HRA Pharma Rare Diseases, expanding its portfolio to address rare diseases like adrenocortical carcinoma and enhancing global market reach. Notable companies in this sector, such as HRA Pharma, Servier Laboratories, Roche Holding, and others, are playing pivotal roles in advancing ACC treatment.

Geographically, North America led the market in 2025, with Asia-Pacific forecasted as the fastest-growing region through 2030. Significant growth is anticipated across regions including Western and Eastern Europe, South America, and the Middle East.

Reasons to Purchase:

Markets Covered:

1) By Type: Localized; Metastatic

2) By Therapy: Surgery; Chemotherapy; Targeted and Radiation Therapy

3) By End User: Hospitals; Oncology Centers; Medical Centers

Subsegments: Includes breakdowns by type, therapy, and metastasis stages.

Companies Mentioned: Key players include HRA Pharma, Servier Laboratories, Roche, Merck, AstraZeneca, Eli Lilly, Sanofi, Ipsen, and others.

Countries: Includes markets like Australia, Brazil, China, France, Germany, India, and more.

Regions: Spanning Asia-Pacific, Southeast Asia, Europe, North America, and others.

Time Series: Data spans five years historic and ten years forecast.

Data: Includes data on market size, growth, GDP ratios, and expenditure per capita.

Data Segmentation: Covers country, regional data, market share, and competitor analysis.

Delivery Format: Available in Word, PDF, or Interactive + Excel Dashboard.

Key Attributes

The companies featured in this Adrenocortical Carcinoma market report include:

For more information about this report visit https://www.researchandmarkets.com/r/qhak86

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment